FENCFennec Pharmaceuticals Inc.
$10.65+12% 1Y
$10.65
$5.7752 weeks$12.78
The financials
Fennec Pharmaceuticals Inc. by the numbers
Fennec Pharmaceuticals Inc. (FENC) reported revenue of $18M in Q2 2026 (quarter ended Jun 30, 2026), up 85% from the same quarter a year earlier. That came with net income of $2.0M (11% of revenue). For the full year FY2025, revenue was $45M (−6.1% year on year) and net income −$9.7M.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $18M | $9.7M | +85% |
| Operating income | $1.7M | −$2.7M | to a profit |
| Net income | $2.0M | −$3.2M | to a profit |
| Diluted EPS | $0.05 | −$0.11 | to a profit |